Open AccessAPREPITANT, A NEWER ANTIEMETIC IN CHEMOTHERAPY INDUCED NAUSEA AND VOMITING
Author(s) -
Preetha Selva,
M Saranya
Publication year - 2015
Publication title -
journal of pharmaceutical and scientific innovation
Language(s) - English
Resource type - Journals
ISSN - 2277-4572
DOI - 10.7897/2277-4572.04219
Subject(s) - aprepitant , antiemetic , vomiting , nausea , medicine , chemotherapy induced nausea and vomiting , anesthesia , pharmacology
Aprepitant is a recently introduced NK1 receptor antagonist. It effectively blocks Substance - P, which is supposed to have emetic action. Hence, this newer drug is being used in patients undergoing chemotherapy to prevent chemotherapy induced nausea and vomiting (CINV). This particular review a rticle gives a bird’s eye view on aprepitant, which is being tried as an adjuvant anti emetic in patients with far advanced cancer .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom